Monteclone-LC Tablet is a combination medication containing Levocetirizine (5mg) and Montelukast (10mg). It is indicated for the treatment of seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria. Levocetirizine, an H1-receptor antagonist, provides effective relief from symptoms such as itching, sneezing, runny nose, and itchy, watery eyes. Montelukast, a leukotriene receptor antagonist, blocks the action of leukotrienes, which are chemical mediators involved in allergic reactions. The combination of these two active ingredients provides a synergistic effect, offering enhanced efficacy and broader spectrum of therapeutic benefits. Monteclone-LC Tablet is available in a standardized dosage form and should be taken once daily, either in the morning or evening. It is contraindicated in patients with hypersensitivity to any of the ingredients, and caution is advised in patients with hepatic or renal impairment, as well as those taking other medications that may interact with the combination. As with all medications, patients should be monitored for potential side effects and contraindications.